Search research articles
Contact Us
Filters
Showing results (211-220 of 224) with videos related to
Page
of 23
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferase
M Belanich, T Randall, M A Pastor, et al.
Clinical Pharmacology and Therapeutics
|
February 20, 2014
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients
N Pinto, E R Gamazon, N Antao, et al.
Age and Ageing
|
August 14, 2015
Falls and fractures 2 years after acute stroke: the North Dublin Population Stroke Study
E L Callaly, D Ni Chroinin, N Hannon, et al.
Cancer Research
|
July 15, 1997
Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft
H S Friedman, S P Johnson, Q Dong, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 1999
Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase
H S Friedman, A E Pegg, S P Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 1998
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma
H S Friedman, D M Kokkinakis, J Pluda, et al.
BMC Primary Care
|
November 10, 2024
Supporting GPs and people with hypertension to maximise medication use to control blood pressure: a pilot cluster RCT of the MIAMI intervention
E C Morrissey, L O'Grady, P J Murphy, et al.
Journal of Human Hypertension
|
January 17, 2014
Ambulatory blood pressure monitoring for risk stratification in obese and non-obese subjects from 10 populations
T W Hansen, L Thijs, Y Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma
H S Friedman, J Pluda, J A Quinn, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2017
NCCN Guidelines Insights: Antiemesis, Version 2.2017
Michael J Berger, David S Ettinger, Jonathan Aston, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 224) with videos related to
Sort By:
Page
of 23
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferase
M Belanich, T Randall, M A Pastor, et al.
Clinical Pharmacology and Therapeutics
|
February 20, 2014
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients
N Pinto, E R Gamazon, N Antao, et al.
Age and Ageing
|
August 14, 2015
Falls and fractures 2 years after acute stroke: the North Dublin Population Stroke Study
E L Callaly, D Ni Chroinin, N Hannon, et al.
Cancer Research
|
July 15, 1997
Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft
H S Friedman, S P Johnson, Q Dong, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 1999
Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase
H S Friedman, A E Pegg, S P Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 1998
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma
H S Friedman, D M Kokkinakis, J Pluda, et al.
BMC Primary Care
|
November 10, 2024
Supporting GPs and people with hypertension to maximise medication use to control blood pressure: a pilot cluster RCT of the MIAMI intervention
E C Morrissey, L O'Grady, P J Murphy, et al.
Journal of Human Hypertension
|
January 17, 2014
Ambulatory blood pressure monitoring for risk stratification in obese and non-obese subjects from 10 populations
T W Hansen, L Thijs, Y Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma
H S Friedman, J Pluda, J A Quinn, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2017
NCCN Guidelines Insights: Antiemesis, Version 2.2017
Michael J Berger, David S Ettinger, Jonathan Aston, et al.
Page
of 23